EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 62 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $857,000 | -44.9% | 108,285 | -45.2% | 0.29% | -39.5% |
| Q2 2022 | $1,555,000 | -31.1% | 197,640 | +6.4% | 0.48% | -48.7% |
| Q1 2022 | $2,256,000 | +1.3% | 185,666 | +2.1% | 0.93% | +3.5% |
| Q4 2021 | $2,226,000 | +65.3% | 181,886 | +40.7% | 0.90% | +18.4% |
| Q3 2021 | $1,347,000 | -38.2% | 129,290 | -46.6% | 0.76% | -21.5% |
| Q2 2021 | $2,178,000 | -28.5% | 242,309 | -19.2% | 0.97% | -41.6% |
| Q1 2021 | $3,048,000 | – | 300,000 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |